Hypertensive Crisis with Epistaxis — 75-Year-Old Female

First, Clarify: Urgency vs. Emergency

This patient's BP of 170/100 mmHg technically does not meet the threshold for hypertensive crisis (≥180/120). It is elevated but falls in Stage 2 hypertension. However, given her epistaxis and age, urgent assessment is warranted.

Step 1 — Immediate Assessment

• Neuro: Headache, confusion, visual changes → stroke/hypertensive encephalopathy
• Cardiac: Chest pain, dyspnea → ACS, acute heart failure, aortic dissection
• Renal: Oliguria, hematuria → hypertensive nephropathy
• Eyes: Fundoscopy for papilledema

Step 2 — Manage the Nosebleed

• Pinch the soft part of nose for 10–15 minutes
• Lean forward, not backward
• Do not delay BP treatment while managing the bleed

Step 3 — Medication Options

A. If Hypertensive Urgency (no organ damage, BP ≥180/120 OR as in this case, urgent but stable)

⚠️ Avoid sublingual nifedipine — it causes unpredictable, precipitous BP drop and has been associated with stroke and MI, especially in elderly.

B. If Hypertensive Emergency (organ damage confirmed) — IV Agents in ICU/ED

Special Considerations in a 75-Year-Old Woman

• Avoid over-aggressive lowering — elderly patients have impaired autoregulation; too-rapid BP reduction can cause falls, syncope, or stroke
• Check renal function before ACE inhibitors (captopril, enalapril)
• Assess for aortic stenosis before vasodilators
• Polypharmacy — review existing medications for interactions
• Osteoporosis risk — a BP drop causing a fall can be catastrophic
• If she is on NSAIDs (common in elderly for arthritis) — these elevate BP and blunt antihypertensives; discontinue if possible

Summary Recommendation

For a 75-year-old woman with BP 170/100 and epistaxis, with no confirmed end-organ damage:

1. Manage the nosebleed with direct pressure
2. Place in calm, seated position (anxiety raises BP)
3. Give oral Captopril 25 mg or oral Amlodipine 5 mg
4. Recheck BP in 30–60 minutes
5. If BP is ≥180/120 or organ damage symptoms develop → escalate to IV therapy in ED setting

⚕️ Disclaimer: This is clinical education information. A licensed provider must evaluate the patient directly and make individualized treatment decisions.

Amlodipine 5 mg + Torsemide 40 mg Combination

Individual Drug Profiles

1. Amlodipine 5 mg (Calcium Channel Blocker)

2. Torsemide 40 mg (Loop Diuretic)

40 mg torsemide ≈ 80–100 mg furosemide in potency. This is a moderate-to-high dose — must be justified clinically.

Is This Combination Appropriate for This Patient?

✅ Rationale FOR the Combination

⚠️ Cautions & Monitoring in a 75-Year-Old Woman

Monitoring Parameters

1. BP check in 1–2 hours (oral onset)
2. Electrolytes (K⁺, Mg²⁺, Na⁺) within 24–48 hours
3. Renal function (BUN, creatinine) in 48–72 hours
4. Daily weight to assess fluid loss
5. Orthostatic BP (lying → standing) — fall prevention
6. Urine output monitoring

Clinical Bottom Line

For this 75-year-old woman with BP 170/100 and epistaxis:

• Amlodipine 5 mg is an excellent, well-tolerated choice ✅
• Torsemide 40 mg is appropriate only if she has signs of fluid overload, heart failure, or chronic diuretic use — it is too aggressive as routine add-on for uncomplicated hypertension at this dose
• If a diuretic is needed for BP alone, consider starting with Hydrochlorothiazide 12.5–25 mg (thiazide) rather than a high-dose loop diuretic
• If torsemide is used, potassium supplementation or a potassium-sparing agent (e.g., spironolactone) should be considered

⚕️ Disclaimer: Clinical decisions must be individualized by the treating provider based on full patient history, labs, and examination findings.

Telmisartan 40 mg + Amlodipine 5 mg Combination

Individual Drug Profiles

1. Telmisartan 40 mg (ARB — Angiotensin Receptor Blocker)

2. Amlodipine 5 mg (CCB — Calcium Channel Blocker)

Why This Combination Works So Well

"Combining drugs from different drug classes can have additive or synergistic effects and lead to greater BP reduction than increasing the dose of one drug... combination therapy targets multiple pathophysiological pathways."

The ARB directly counteracts the ankle edema caused by amlodipine — making this combination particularly well-tolerated.

Combined BP Reduction Expected

Is This Appropriate for This 75-Year-Old Woman?

✅ Strong Indications

⚠️ Cautions & Monitoring

Monitoring Parameters After Starting

1. BP — recheck in 1–2 weeks
2. Serum potassium — within 1–2 weeks (ARB effect)
3. Renal function (BUN, creatinine, eGFR) — within 2–4 weeks
4. Orthostatic BP — lying and standing to assess fall risk
5. Ankle edema — clinical exam at follow-up
6. Electrolytes — periodic monitoring every 3–6 months

Target BP for a 75-Year-Old

Clinical Bottom Line

Telmisartan 40 mg + Amlodipine 5 mg is an excellent, guideline-supported combination for this patient. It is:

• Complementary in mechanism (RAAS + CCB)
• Well-tolerated in elderly women
• Available as a fixed-dose combination (FDC) tablet (e.g., Twynsta®) improving adherence
• Can reduce her BP by ~18–22 mmHg, bringing her closer to target
• The ARB also protects kidneys and counteracts CCB-induced edema

⚕️ Disclaimer: Treatment must be individualized by the treating provider based on full clinical evaluation, comorbidities, and lab values.

Amlodipine 10 mg — Headache & Dizziness in a 75-Year-Old

Why These Symptoms Are Happening

"Side effects of flushing, headache, and edema with dihydropyridine use are related to their potencies as arteriolar dilators."

Immediate Assessment — Do This First

Management Options

Option 1 — Dose Reduction ✅ (Most Appropriate)

• Symptoms are dose-dependent; lower dose reduces vasodilatory side effects
• BP can be maintained by optimizing telmisartan (up-titrate to 80 mg if needed)
• Most practical and safest first step in a 75-year-old

Option 2 — Switch to a Different CCB

Option 3 — Add a Third Agent Instead

• Reduce amlodipine to 5 mg + add Hydrochlorothiazide 12.5 mg or Indapamide 1.5 mg (thiazide diuretics)
• This maintains BP control through a different mechanism while reducing the CCB dose and its side effects

Option 4 — Symptomatic Management (Short-term only)

Summary — Recommended Action Plan

Step 1: Check BP (lying + standing) and HR right now
Step 2: Rule out stroke / serious neurological cause
Step 3: Reduce Amlodipine 10 mg → 5 mg
Step 4: Up-titrate Telmisartan 40 mg → 80 mg to compensate
Step 5: If BP still uncontrolled, add Indapamide 1.5 mg (thiazide)
Step 6: If headache/dizziness persist at 5 mg, switch to Lercanidipine
Step 7: Recheck BP and symptoms in 1–2 weeks

Key Point for Elderly Patients

In a 75-year-old woman, dizziness from amlodipine is not just a comfort issue — it is a fall and fracture risk. A hip fracture in this age group carries up to 30% mortality at 1 year. Dose reduction is not optional — it is a safety imperative.

⚕️ Disclaimer: All medication changes must be made by the treating provider based on full clinical assessment.

Recurrent Epistaxis Despite Antihypertensive Medication — What To Do Now

Step 1 — Immediate Epistaxis Management (Right Now)

Anterior Epistaxis (most common — Kiesselbach's plexus)

If Bleeding is Moderate to Severe / Won't Stop

• Formal nasal endoscopy to identify exact bleeding source
• Bipolar electrical cautery for definitive control
• Nasal packing (Merocel, Vaseline gauze) as a backup option

Posterior Epistaxis (less common, more serious — suspect if packing fails)

• Requires hospitalization, cardiac monitoring, supplemental oxygen
• Foley catheter balloon / dual-balloon epistaxis device
• ENT referral mandatory
• Antibiotic cover to prevent toxic shock syndrome (S. aureus)

Per Textbook of Family Medicine (p. 416): "If bleeding continues to be a problem, the patient should be referred to an ENT consultant for a complete evaluation of the nasal cavities and possible cautery."

Step 2 — Why Is Epistaxis Recurring? Rule These Out

Step 3 — Medication Review & Adjustment

Problem with Current Regimen

Revised Medication Strategy

STEP 1: Reduce Amlodipine 10 mg → 5 mg  (eliminates headache/dizziness)
STEP 2: Up-titrate Telmisartan 40 mg → 80 mg  (compensates for CCB dose reduction)
STEP 3: Add Indapamide SR 1.5 mg OR HCTZ 12.5 mg  (third agent if BP uncontrolled)

This triple combination is guideline-supported for resistant/uncontrolled hypertension and is well-tolerated in elderly patients.

Step 4 — Local Nasal Care to Prevent Future Episodes

Step 5 — When to Refer / Escalate

• Bleeding does not stop after 20–30 minutes of direct pressure
• Bleeding is coming from both nostrils or down the throat (posterior bleed)
• Signs of significant blood loss: pallor, tachycardia, hypotension
• She is on anticoagulants (warfarin, DOACs) with uncontrolled bleeding
• BP remains >180/120 mmHg despite medications

Summary Action Plan

RIGHT NOW:
✅ Direct pressure + oxymetazoline spray for active bleed
✅ Check BP (lying + standing) and HR
✅ Review all medications — stop NSAIDs, aspirin if not essential

THIS VISIT:
✅ Silver nitrate cautery if visible bleeding point identified
✅ Reduce Amlodipine 10 mg → 5 mg
✅ Increase Telmisartan 40 mg → 80 mg
✅ Start saline nasal spray + Vaseline nightly

FOLLOW-UP (1–2 weeks):
✅ Recheck BP and electrolytes
✅ If BP uncontrolled → add Indapamide 1.5 mg
✅ If epistaxis recurs → ENT referral for endoscopy + cautery
✅ Check CBC, PT/INR, bleeding time if unexplained recurrence

⚕️ Disclaimer: This guidance is for clinical education. A licensed provider must directly evaluate and manage this patient based on the full clinical picture.

Telmisartan 40–80 mg — Once Daily

Amlodipine 5–10 mg — Once Daily

Comparison Table

Key Clinical Point for This Patient

Both drugs are specifically preferred in elderly patients because their once-daily dosing improves adherence — elderly patients with polypharmacy are more likely to forget multi-dose regimens.

Best Practice for Dosing Time:

• Take both together in the morning after breakfast — simplifies routine, improves compliance
• Alternatively, amlodipine can be taken at bedtime — peak vasodilation occurs during sleep, which may reduce daytime headache and dizziness (especially helpful since she complained of these side effects)

⚕️ Disclaimer: Final prescribing decisions must be made by the treating provider.